Andrographolide Inhibits Inflammatory Cytokines Secretion in LPS-Stimulated RAW264.7 Cells through Suppression of NF-<i>κ</i>B/MAPK Signaling Pathway

<div>Effect of Andrographolide on morphologic changes and viability of RAW264.7 cells. (a) represents cells in control group; (b) represents cells treated by LPS; (c)–(e) represent cells treated with different concentration Andrographolide (6.25, 12.5, and 25 <i>μ</i>g/ml) for 1 h and LPS for another 18 h, respectively; (f) represents the effect of Andrographolide on the cell viability of RAW264.7 cells in control, LPS, and Andrographolide treated groups. Results are representative of three (f) independent experiments.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Andrographolide Inhibits Inflammatory Cytokines Secretion in LPS-Stimulated RAW264.7 Cells through Suppression of NF-<i>κ</i>B/MAPK Signaling Pathway 

Figure 2 | Andrographolide Inhibits Inflammatory Cytokines Secretion in LPS-Stimulated RAW264.7 Cells through Suppression of NF-κB/MAPK Signaling Pathway 